2 Firms Will Lead Investor Suit Over GW Pharma's $7.2B Deal
A California federal judge has appointed Monteverde & Associates and Kahn Swick & Foti as co-lead counsel of a proposed securities class action against GW Pharmaceuticals over claims that it misled...To view the full article, register now.
Already a subscriber? Click here to view full article